Retractable Technologies Declares Preferred Dividend Amid Tariff Pressures

Retractable Technologies ( (RVP) ) has issued an announcement.

Retractable Technologies, Inc., a maker of safety syringes, needles, and related medical devices, reported that revenues for 2025 rose 15.8% to approximately $38.3 million, driven by higher domestic VanishPoint and EasyPoint needle sales and a 64.0% jump in international revenue. Despite the top-line growth, the company’s operating loss was essentially flat at $21.2 million, cash fell by $1.6 million to $2.6 million, and management highlighted that elevated operating costs and roughly $1.8 million in tariff expenses on China-sourced products—subject to a prevailing 120% tariff rate as of March 9, 2026—are expected to continue to materially pressure its operations and financial position.

On March 27, 2026, the company also announced the declaration of a dividend to holders of its Series II and Series III Class B Convertible Preferred Stock, underscoring a continued capital return to those shareholders even as tariffs and post-pandemic demand normalization complicate its path back to profitability. Management noted that comparisons with the pandemic-driven years 2020–2023 are difficult, and ongoing uncertainty around U.S. trade policy and competitive pressures in the safety device market pose significant risks for future performance and liquidity.

The most recent analyst rating on (RVP) stock is a Hold with a $0.66 price target. To see the full list of analyst forecasts on Retractable Technologies stock, see the RVP Stock Forecast page.

Spark’s Take on RVP Stock

According to Spark, TipRanks’ AI Analyst, RVP is a Neutral.

The score is held down primarily by weak profitability (negative margins) and negative operating cash flow despite low leverage. Technical indicators also lean bearish with the price below key moving averages and negative MACD. Valuation offers limited support because the negative P/E reflects ongoing losses, and no common dividend yield is provided.

To see Spark’s full report on RVP stock, click here.

More about Retractable Technologies

Retractable Technologies, Inc. is a medical device manufacturer focused on safety-engineered syringes, needles, blood collection devices, and IV catheters. Its VanishPoint and Patient Safe lines are designed to prevent needlestick injuries, reuse, and catheter-related bloodstream infections, while its EasyPoint retractable needle is compatible with multiple syringe types and is sold through specialty and general line distributors.

Average Trading Volume: 54,142

Technical Sentiment Signal: Sell

Current Market Cap: $20.44M

Find detailed analytics on RVP stock on TipRanks’ Stock Analysis page.